Concepedia

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Cristiana Sessa, Judith Balmañà, Sharon L. Bober, Maria João Cardoso, N. Colombo, Giuseppe Curigliano, Susan M. Domchek, D. Gareth Evans, D. Fischerová, Nadia Harbeck,

Annals of Oncology · 2022 · 276 citations · 83 references

DOIFull text

Open access

Concepts

References

83

Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Karoline Kuchenbaecker, John L. Hopper, Daniel R. Barnes et al. · JAMA · 2017 · 2.9K citations · Full text

, , +17

Mammographic Density and the Risk and Detection of Breast Cancer

Norman F. Boyd, Helen Guo, Lisa J. Martin et al. · New England Journal of Medicine · 2007 · 2.5K citations · Full text

, , +14

Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

Andrew Tutt, Judy E. Garber, Bella Kaufman et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

, , +17

Cancer Risks in BRCA2 Mutation Carriers

JNCI Journal of the National Cancer Institute · 1999 · 1.5K citations · Full text

, , +17

Association of Risk-Reducing Surgery in &lt;emph type="ital"&gt;BRCA1&lt;/emph&gt; or &lt;emph type="ital"&gt;BRCA2&lt;/emph&gt; Mutation Carriers With Cancer Risk and Mortality

Susan M. Domchek · JAMA · 2010 · 1.5K citations · Full text

, , +17